Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript
Compared to Estimates, Globus Medical (GMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Globus Medical (GMED) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
GMED vs. IDXX: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
GMED rides on NuVasive synergies, strong cash flow and rapid innovation, but macro pressures and rising costs cloud its near-term outlook.
All You Need to Know About Globus Medical (GMED) Rating Upgrade to Strong Buy
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why Is Globus Medical (GMED) Down 9.2% Since Last Earnings Report?
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?
3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes
GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.
Bridgefront Capital LLC Invests $667,000 in Globus Medical, Inc. $GMED
Bridgefront Capital LLC acquired a new stake in Globus Medical, Inc. (NYSE: GMED) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 11,642 shares of the medical device company's stock, valued at approximately $667,000. Several other institutional investors and hedge funds also
Bears are Losing Control Over Globus Medical (GMED), Here's Why It's a 'Buy' Now
Globus Medical (GMED) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
